Progyny, Inc.

Thank you for holding. We look forward to talking with you soon. Please hold the line, and we'll be right back with you.

Good afternoon, ladies and gentlemen, and welcome to the progeny third quarter 2021 earnings call. At this time, all participants are in a listen-only mode, and the floor will be open for your questions and comments following the presentation. It is now my pleasure to turn the floor over to your host, James Hart. Sir, the floor is yours.

Thank you, Catherine, and good afternoon, everyone. Welcome to our third quarter conference call. With me today are David Schlanger, CEO of Progeny, Pete Ineske, President and COO, and Mark Livingston, CFO. We will begin with some prepared remarks before we open the call for your questions. Before we begin, I'd like to remind you that today's call contains forward-looking statements, including but not limited to, statements about our financial outlook for both the fourth quarter and full year of 2021, including our expected utilization rates and mix, the impact of COVID-19, including variance on our business, clients, member activity, and industry operations, our ability to acquire new clients and retain existing clients, our plans for and the timing of leadership and board changes, our market opportunity, size, and expectation of long-term growth, Our corporate governance plans, business performance, industry outlook, strategy, future investments, plans and objectives, and other non-historical statements as further described in our press release that was issued this afternoon. These forward-looking statements are subject to certain risks, uncertainties, and assumptions, including those related to progeny's growth, market opportunities, and general economic and business conditions. We debate these statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. Although we believe these expectations are reasonable, we undertake no obligation to revise any statements to reflect changes that occur after this call. Descriptions of these and other risks that could cause actual results to differ materially from these forward-looking statements are discussed in our periodic and current reports filed with the SEC, including in the section entitled Risk Factors in our most recent 10Q. During the call, we will also refer to non-GAAP financial measures, such as adjusted EBITDA and adjusted EBITDA margin. Reconciliations with most comparable GAAP measures are also available in the press release, which is available at investors.progeny.com. I would now like to turn the call over to David.